Top Industry Leaders in the Digital Therapeutics Market
Latest Digital Therapeutics Companies Update
Better Therapeutics launches AspyreRx platform tailors diabetes management strategies for individual patients, providing personalized support and medication adherence tools.
Livongo debuts new hypertension and anxiety apps additions broaden Livongo's DTx portfolio beyond diabetes, targeting wider audiences and diversifying their offerings.
FDA approves Pear Therapeutics' PERSOS for PTSD marks a significant milestone for PTSD treatment, with PERSOS becoming the first prescription DTx approved for a mental health condition.
Akili Interactive Labs partners with Otsuka Pharmaceutical collaboration focuses on developing and commercializing DTx solutions for neurological disorders, leveraging Akili's EndeavorRx platform for cognitive improvement.
Pear Therapeutics partners with Boehringer Ingelheim partnership expands Pear's reach in mental health DTx, focusing on developing solutions for schizophrenia and treatment-resistant depression.List of Digital Therapeutics Key Companies in the Market
- Proteus Digital Health (US)
- Wellthy Therapeutics (India)
- Propeller Health (US)
- SE (Sweden)
- BehaVR (US)
- Akili Interactive Labs (US)
- Hinge Health (US)
- Better Therapeutics (US)
- Virta Health (US)
- Happify (US)
- Mindable Health (Germany)